Trials / Sponsors / Taiga Biotechnologies, Inc.
Taiga Biotechnologies, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis Myelofibrosis, Acute Myelogenous Leukemia | Phase 1 | 2022-09-01 |
| Unknown | Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency Severe Combined Immunodeficiency | Phase 1 | 2021-08-01 |
| Unknown | Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies Cancer, Tumor, Solid, Refractory Cancer | Phase 1 / Phase 2 | 2021-01-25 |
| Unknown | Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhi Stage III Melanoma, Stage IV Melanoma | Phase 1 | 2019-06-02 |